Szanyi, J., Kremláček, J., Kubová, Z., Langrová, J., Kuba, M., Kapla, J., Gebouský, P., and Plíšek, S.
Introduction: The aim of our study was to verify the possibility of early identification of HIV-related neural injury using visual evoked potentials (VEPs) in neurologically asymptomatic HIV seropositives. In the CART (combination antiretroviral therapy) era, the prevalence of neurocognitive impairment remains high, up to 50%, and HIV-associated neurocognitive disorder (HAND) has shifted towards a milder clinical presentation. Such a mild clinical presentation can escape detection [1]. Methods: The examination consisted of the Montreal Cognitive Assessment (MoCA) [2], and VEPs to pattern-reversal, motion-onset stimulation (radial movement), and of visual ERPs recorded during an odd-ball test (http://www.lfhk.cuni.cz/elf). Subjects: 9 homosexual men and 3 heterosexually infected women were examined in this study. All patients had ⩾350×106 CD4 cells/l blood at inclusion. The duration of the HIV infection was 0.5 – 7years, and mean age of the patients was 35 (24–50) years. Results: P100 potential was recorded with no alteration in the VEP amplitude or latency. However, in 5 patients with CD4 counts 350–750×106cells/l, there was prolonged latency of the N160 peak compared to the reference values obtained in our laboratory, which suggests a dysfunction of the motion-processing (magnocellular system or the dorsal cortical stream) [3]. P300 latencies and MoCA results were within the normal range in all HIV patients. Conclusions: Our data suggest that motion-onset VEPs may be a sensitive measure of subclinical visual pathway dysfunction in early HIV-1 infection, however, we did not reveal any cognitive decline in this pilot group. Subsequently, the patients will be investigated using VEPs and visual ERPs at six-month intervals to evaluate the long-term development of the visual pathway involvement in HIV patients. [ABSTRACT FROM AUTHOR]